We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Oral Administration of Oyster Peptide Prevents Bone Loss in Ovariectomized Mice
Summary
Researchers investigated whether oral administration of an oyster-derived peptide (P-CG-01, YRGDVVPK) could prevent bone loss in ovariectomized mice used as an osteoporosis model, finding that the peptide restored bone mineral density to sham surgery levels. The results suggest that this food-derived peptide has potential as an orally bioavailable agent for osteoporosis prevention, offering a non-injection alternative to existing peptide therapies.
Osteoporosis is a disordered metabolic disease occurred congenitally or secondary. Although peptide agents have been approved to prevent osteoporosis administrated through subcutaneous injection, rare reports focused on peptide oral administration for preventive purpose. An eight peptide, P‐CG‐01 (YRGDVVPK) derived from oyster protein hydrolysates in gastrointestinal tract can promote the proliferation of osteoblast in vitro . In this study, ovariectomized mouse model was used to investigate the osteogenesis activity of P‐CG‐01. Bone mineral density value was recovered to the level of Sham by treatment of peptide [30 mg/kg body weight (BW)] in the ovariectomized mice. Peptide was detected at an average concentration of 803.16 ng/mL in serum from those mice after gavage. The peptide was labelled with fluorescein isothiocyanate and detected in the cytoplasm of osteoblast by confocal microscopes. ERK2 and BMP‐2 expression was increased 1.5‐ and 3.8‐fold, respectively, by the treatment of peptide. Our results suggest that P‐CG‐01 can inhibit the development of osteoporosis in ovariectomized mice.
Sign in to start a discussion.
More Papers Like This
Pharmacodynamic Material Basis and Potential Mechanism Study of Spatholobi Caulis in Reversing Osteoporosis
Researchers investigated the pharmacological mechanisms of Spatholobi Caulis (SC) in reversing osteoporosis, finding it operates through multi-component, multi-target pathways with the AGE-RAGE signaling pathway identified as the primary regulatory mechanism.
Mollusk shells as marine bioactive materials: Composition, bioactivities, and prospects for food and health applications
Researchers reviewed the bioactive properties of marine mollusk shells, which are generated in large quantities as seafood processing waste. They found that shell-derived compounds exhibit antioxidant, anti-inflammatory, antimicrobial, and bone-building properties, supporting potential uses as natural calcium sources and functional food ingredients. The study highlights an opportunity to turn an abundant waste material into valuable health and food science applications.
Bridging relevance between microplastics, human health and bone metabolism: Emerging threats and research directions
Researchers reviewed how microplastics — tiny plastic fragments that accumulate in tissues throughout the body — may disrupt bone metabolism by triggering inflammation, oxidative stress, and hormonal interference, raising concern that widespread microplastic exposure could contribute to bone diseases like osteoporosis.
Chronic exposure to polystyrene microplastics triggers osteoporosis by breaking the balance of osteoblast and osteoclast differentiation
Mice that drank water containing polystyrene microplastics for six months developed significant bone loss resembling osteoporosis, with weakened bone structure and reduced bone formation. The microplastics triggered inflammation in bone stem cells and disrupted the balance between bone-building and bone-breaking processes, suggesting that long-term microplastic exposure could contribute to bone disease.
Effects of Polystyrene Microplastics on Bone-related Protein Expression, Mineralization Capacity, and Mitochondrial Function in Osteoblast-like Cells (mg-63)
Osteoblast-like cells (MG-63) were exposed to polystyrene microplastics at 5–50 µg/mL, and bone-related protein expression, mineralisation capacity, and mitochondrial function were assessed. PS-MPs were internalised and reduced mineralisation and osteocalcin levels while impairing mitochondrial bioenergetics, suggesting microplastics may negatively affect bone cell function.